Literature DB >> 12490715

The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.

Jian Du1, Gregory J Hannon.   

Abstract

Alterations in the activity of the centrosomal kinase, Aurora-A/STK15, have been implicated in centrosome amplification, genome instability and cellular transformation. How STK15 participates in all of these processes remains largely mysterious. The activity of STK15 is regulated by phosphorylation and ubiquitin-mediated degradation, and physically interacts with protein phosphatase 1 (PP1) and CDC20. However, the precise roles of these modifications and interactions have yet to be fully appreciated. Here we show that STK15 associates with a putative tumor and metastasis suppressor, NM23-H1. STK15 and NM23 were initially found to interact in yeast in a two-hybrid assay. Association of these proteins in human cells was confirmed by co-immunoprecipitation from cell lysates and biochemical fractionation indicating that STK15 and NM23-H1 are present in a stable, physical complex. Notably, SKT15 and NM23 both localize to centrosomes throughout the cell cycle irrespective of the integrity of the microtubule network in normal human fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490715      PMCID: PMC140054          DOI: 10.1093/nar/gkf678

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  56 in total

1.  MAPK mediates RAS-induced chromosome instability.

Authors:  H I Saavedra; K Fukasawa; C W Conn; P J Stambrook
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

Review 2.  Centrosome duplication. a centriolar pas de deux.

Authors:  T Stearns
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

3.  Cell biology. Do centrosome abnormalities lead to cancer?

Authors:  J Marx
Journal:  Science       Date:  2001-04-20       Impact factor: 47.728

4.  Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations.

Authors:  B M Ghadimi; D L Sackett; M J Difilippantonio; E Schröck; T Neumann; A Jauho; G Auer; T Ried
Journal:  Genes Chromosomes Cancer       Date:  2000-02       Impact factor: 5.006

5.  Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.

Authors:  A Tutt; A Gabriel; D Bertwistle; F Connor; H Paterson; J Peacock; G Ross; A Ashworth
Journal:  Curr Biol       Date:  1999-10-07       Impact factor: 10.834

6.  Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.

Authors:  Y Miyoshi; K Iwao; C Egawa; S Noguchi
Journal:  Int J Cancer       Date:  2001-05-01       Impact factor: 7.396

Review 7.  The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer.

Authors:  J L Salisbury
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

8.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.

Authors:  H Zhou; J Kuang; L Zhong; W L Kuo; J W Gray; A Sahin; B R Brinkley; S Sen
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  The non-catalytic domain of the Xenopus laevis auroraA kinase localises the protein to the centrosome.

Authors:  R Giet; C Prigent
Journal:  J Cell Sci       Date:  2001-06       Impact factor: 5.285

10.  Centrosomes enhance the fidelity of cytokinesis in vertebrates and are required for cell cycle progression.

Authors:  A Khodjakov; C L Rieder
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

View more
  17 in total

1.  Nm23-H1 can induce cell cycle arrest and apoptosis in B cells.

Authors:  Tathagata Choudhuri; Masanao Murakami; Rajeev Kaul; Sushil K Sahu; Suchitra Mohanty; Subhash C Verma; Pankaj Kumar; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-06-11       Impact factor: 4.742

Review 2.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

Review 3.  Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1.

Authors:  Natascia Marino; Jean-Claude Marshall; Patricia S Steeg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

Review 4.  Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.

Authors:  Natascia Marino; Joji Nakayama; Joshua W Collins; Patricia S Steeg
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

5.  Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.

Authors:  Alexandra Klein; Daniela Flügel; Thomas Kietzmann
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

6.  Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion.

Authors:  Jian Du; Gregory J Hannon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

Review 7.  The NM23 family in development.

Authors:  Aikaterini Bilitou; Julie Watson; Anton Gartner; Shin-Ichi Ohnuma
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

8.  Astrin regulates Aurora-A localization.

Authors:  Jian Du; Sandra Jablonski; Tim J Yen; Gregory J Hannon
Journal:  Biochem Biophys Res Commun       Date:  2008-03-24       Impact factor: 3.575

Review 9.  Regulators affecting the metastasis suppressor activity of Nm23-H1.

Authors:  Hag Dong Kim; Buhyun Youn; Tae-Sung Kim; Sang-Hwa Kim; Hyun-Seock Shin; Joon Kim
Journal:  Mol Cell Biochem       Date:  2009-04-18       Impact factor: 3.396

10.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.